AtheroMed
Innovative solutions for peripheral arterial disease since 2006, based in Menlo Park, California.
Innovative solutions for peripheral arterial disease since 2006, based in Menlo Park, California.
AtheroMed is a biotechnology startup based in Menlo Park, California, specializing in innovative solutions for peripheral arterial disease. Founded in 2006, the company has been dedicated to developing treatments for this critical health issue. AtheroMed's commitment to addressing peripheral arterial disease has attracted attention and investment, with their last round of Debt Financing amounting to $4.35M on 10 December 2013. While the details of their investors for this round are not publicly available, this investment signifies a recognition of the potential and value of AtheroMed's work in the biotechnology and healthcare industries. With a focus on innovation and a solid foundation, AtheroMed continues to drive progress in the field of peripheral arterial disease treatment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $4.35M | - | 10 Dec 2013 | |
| Private Equity Round | $5.96M | 4 |
|
03 Apr 2013 |
| Private Equity Round | $13.00M | 1 |
|
01 Apr 2012 |
| Series D | $4.48M | 3 |
|
07 Mar 2012 |
| Venture Round | $7.53M | - | 09 May 2011 |
We care about your data, and we'd love to use cookies make your experience better.